← back to search

Michael C. Jensen

Brookhaven National Laboratory · US
Area of research
Oncology · Immunology
Research interest
Research interests include CAR-T cell therapy research, Immunotherapy and Immune Responses, Immune Cell Function and Interaction, and Virus-based gene therapy research.
h-index
81
citations
33,581
works
624
NIH funding
primary concept
Medicine
email

Recent publications

263 Engineering mercaptopurine-resistant CD19CAR T cells with a mutant phosphoribosyl pyrophosphate synthetase I (PRPS1)
Regular and Young Investigator Award Abstracts 2025cited by 0position: middledoi
Differential protein-protein interactions underlie signaling mediated by the TCR and a 4-1BB domain-containing CAR.
2024cited by 9position: contributordoi
First-in-human comparison of second- versus third-generation L1CAM-specific CAR T cells in patients with primary refractory or relapsed neuroblastoma
2024cited by 3position: contributordoi
Genome-wide CRISPRa screens nominate modulators of CAR T cell survival within distinct tumor cytokine milieus
2024cited by 1position: contributordoi
233 Early experience on ENLIGHTen-01: a phase 1 study of FITC-E2 CAR-T cells with CAR adaptor molecule UB-TT170 for relapsed/refractory osteosarcoma
Regular and Young Investigator Award Abstracts 2024cited by 0position: middledoi
DIPG-11. PRECLINICAL EFFICACY OF B7-H3 CAR T CELLS IN COMBINATION WITH ONC206
Neuro-Oncology 2024cited by 0position: middledoi
Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety.
2023cited by 214position: contributordoi
Pre-clinical validation of a pan-cancer CAR-T cell immunotherapy targeting nfP2X7.
2023cited by 18position: contributordoi
A stem cell epigenome is associated with primary nonresponse to CD19 CAR T cells in pediatric acute lymphoblastic leukemia
Blood Advances 2023cited by 17position: middledoi
Data from FGFR4-Targeted Chimeric Antigen Receptors Combined with Anti-Myeloid Polypharmacy Effectively Treat Orthotopic Rhabdomyosarcoma
2023cited by 0position: contributordoi
Data from Modified Manufacturing Process Modulates CD19CAR T-cell Engraftment Fitness and Leukemia-Free Survival in Pediatric and Young Adult Subjects
2023cited by 0position: contributordoi
Supplementary Figure from B7-H3 Specific CAR T Cells for the Naturally Occurring, Spontaneous Canine Sarcoma Model
2023cited by 0position: contributordoi
Data from B7-H3 Specific CAR T Cells for the Naturally Occurring, Spontaneous Canine Sarcoma Model
2023cited by 0position: contributordoi
Supplementary Data from Modified Manufacturing Process Modulates CD19CAR T-cell Engraftment Fitness and Leukemia-Free Survival in Pediatric and Young Adult Subjects
2023cited by 0position: contributordoi
Supplementary Figure from B7-H3 Specific CAR T Cells for the Naturally Occurring, Spontaneous Canine Sarcoma Model
2023cited by 0position: contributordoi
Supplementary Data from FGFR4-Targeted Chimeric Antigen Receptors Combined with Anti-Myeloid Polypharmacy Effectively Treat Orthotopic Rhabdomyosarcoma
2023cited by 0position: contributordoi
Data from Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety
2023cited by 0position: contributordoi
Supplementary Data from FGFR4-Targeted Chimeric Antigen Receptors Combined with Anti-Myeloid Polypharmacy Effectively Treat Orthotopic Rhabdomyosarcoma
2023cited by 0position: contributordoi
Data from FGFR4-Targeted Chimeric Antigen Receptors Combined with Anti-Myeloid Polypharmacy Effectively Treat Orthotopic Rhabdomyosarcoma
2023cited by 0position: contributordoi
Data from Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety
2023cited by 0position: contributordoi
Supplementary Data from Modified Manufacturing Process Modulates CD19CAR T-cell Engraftment Fitness and Leukemia-Free Survival in Pediatric and Young Adult Subjects
2023cited by 0position: contributordoi
Data from B7-H3 Specific CAR T Cells for the Naturally Occurring, Spontaneous Canine Sarcoma Model
2023cited by 0position: contributordoi
Supplementary Data from Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety
2023cited by 0position: contributordoi
Data from Modified Manufacturing Process Modulates CD19CAR T-cell Engraftment Fitness and Leukemia-Free Survival in Pediatric and Young Adult Subjects
2023cited by 0position: contributordoi
Supplementary Data from Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety
2023cited by 0position: contributordoi
Rationally designed modular STAT-activating scaffolds enforce cell-intrinsic transcriptional programs augmenting the anti-tumor potency of CAR T cells
2023cited by 0position: contributordoi
FGFR4-Targeted Chimeric Antigen Receptors Combined with Anti-Myeloid Polypharmacy Effectively Treat Orthotopic Rhabdomyosarcoma.
2022cited by 25position: contributordoi
B7-H3 Specific CAR T Cells for the Naturally Occurring, Spontaneous Canine Sarcoma Model.
2022cited by 24position: contributordoi
Modified Manufacturing Process Modulates CD19CAR T-cell Engraftment Fitness and Leukemia-Free Survival in Pediatric and Young Adult Subjects.
2022cited by 21position: contributordoi
Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis
Nature Medicine 2021cited by 302position: middledoi

Grants

IGERT: An Entrepreneurial Ph.D. Education in Fuel Cell Manufacturing, Materials Development, and Modeling
NSF0504361$3,162,4302005–2012PIRePORTER
The Critical Heat Flux Condition in Micro-Channels
NSF0245642$540,6302003–2007PIRePORTER
Plastics Engineering Technology Scholarships
NSF0220827$335,5002002–2007PIRePORTER
Conference: Special Sessions to Encourage Collaboration & Interaction Across Disciplinary Boundaries at the IEEE Internat'l Symp. to be held in Salt Lake City, Utah 7/16-21/2000.
NSF0002139$6,9902000–2002PIRePORTER
Workshop on RF Micromachining and MEMS Technology for Wireless Communications Systems
NSF9911096$42,0001999–2001PIRePORTER
An Experimental and Numerical Investigation of Turbulent Variable Fluid Property Heat Transfer and Fluid Flow in Enhanced Tubes
NSF9412596$255,9711994–1999PIRePORTER
An Experimental and Numerical Investigation of Shellside Boiling in Horizontal Tube Bundles
NSF9008435$199,4681990–1994PIRePORTER
Critical Heat Flux in Horizontal Inline and Staggered Tube Arrays (REU Supplement)
NSF8704693$100,0581987–1989PIRePORTER
Two-Phase Crossflow Boiling Heat Transfer in Horizontal Inline and Staggered Tube Arrays
NSF8319596$93,8681984–1986PIRePORTER
The Effect of Twisted-Tape Swirl Generators on Saturated Forced-Convection Boiling Heat Transfer (Mechanical Engineering)
NSF8117226$80,1681982–1984PIRePORTER
Travel to Attend Nato Advanced Study Institute On: Two-PhaseFlows and Heat Transfer, Istanbul, Turkey, August 16 - 27, 1976
NSF7623589$8431976–1977PIRePORTER

Frequent collaborators

· 24 papers (2019–2024)Julie R. Park · University of Tennessee at Knoxville11 papers (2017–2024)Rimas J. Orentas · Lentigen Technology (United States)9 papers (2021–2024)Kristy Seidel · Seattle Children's Hospital7 papers (2021–2024) · 7 papers (2021–2024) · 7 papers (2021–2024) · 6 papers (2022–2024) · 6 papers (2022–2024)Stephen Gottschalk · Texas Children's Hospital5 papers (2022–2023)Alan S. Wayne · University of Southern California5 papers (2022–2023)Dimiter S. Dimitrov · University of Pittsburgh5 papers (2022–2023)Adam Beebe · Children’s Institute5 papers (2022–2023)Brett Schroeder · National Institute of Mental Health5 papers (2022–2023)Adam Cheuk · National Cancer Institute5 papers (2022–2023)Himaly Shinglot · Northwestern University5 papers (2022–2023)Karan Kohli · University of Washington5 papers (2022–2023)Beverly Torok-Storb · Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa5 papers (2022–2023) · 5 papers (2022–2023)Juliana Chi Kei Ng · Northwestern University5 papers (2022–2023)Borislav A. Alexiev · Northwestern University5 papers (2022–2023)